Search

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2025

Treating DR with OTX-TKI

Katherine E. Talcott, MD

Show Description +

Dr. Talcott provides a look at the ultra-widefield retinal leakage assessment in patients with diabetic retinopathy after treatment with OTX-TKI (Ocular Therapeutix), an axitinib hydrogel, in the phase 1 HELIOS trial.

Posted: 8/06/2025

Keywords:

retina-meeting-recap

•

OTX-TKI

•

Ocular Therapeutix

•

TKI

•

Diabetic Retinopathy

•

Ultra-Widefield Retinal Imaging

•

leakage

•

axitinib hydrogel

•

HELIOS

•

Clinical Trials

Up Next

An Oral Option for Stargardt Disease: New Data

An Oral Option for Stargardt Disease: New Data

Kenneth C. Fan, MD, MBA

Optogenetics for RP: 126-Week Data

Optogenetics for RP: 126-Week Data

David S. Liao, MD, PhD

ILM Flaps: 10 Years of Data

ILM Flaps: 10 Years of Data

Zofia A. Nawrocka, MD, PhD

When to Treat with Pegcetacoplan

When to Treat with Pegcetacoplan

Roger A. Goldberg, MD, MBA

Treatment Burden: EYP-1901 Versus Aflibercept

Treatment Burden: EYP-1901 Versus Aflibercept

Avni P. Finn, MD, MBA

Pharmacodynamics of ABBV-RGX-314

Pharmacodynamics of ABBV-RGX-314

Robert L. Avery, MD

The PDS Versus Anti-VEGF Injections in the Fellow Eye

The PDS Versus Anti-VEGF Injections in the Fellow Eye

Jordan Graff, MD, FACS

UBX1325 For DME: Phase 2 Data

UBX1325 For DME: Phase 2 Data

Dante Pieramici, MD

Switching Agents in DME

Switching Agents in DME

Michael Javaheri, MD

Treating Underrepresented Patients With DME

Treating Underrepresented Patients With DME

Andres Emanuelli, MD

Back to All Videos

Treating DR with OTX-TKI

Katherine E. Talcott, MD

Dr. Talcott provides a look at the ultra-widefield retinal leakage assessment in patients with diabetic retinopathy after treatment with OTX-TKI (Ocular Therapeutix), an axitinib hydrogel, in the phase 1 HELIOS trial.

Posted: 8/06/2025

Keywords:

retina-meeting-recap

•

OTX-TKI

•

Ocular Therapeutix

•

TKI

•

Diabetic Retinopathy

•

Ultra-Widefield Retinal Imaging

•

leakage

•

axitinib hydrogel

•

HELIOS

•

Clinical Trials

Please log in to leave a comment.

More From ASRS: 2025 Coverage

An Oral Option for Stargardt Disease: New Data

An Oral Option for Stargardt Disease: New Data

Kenneth C. Fan, MD, MBA

Optogenetics for RP: 126-Week Data

Optogenetics for RP: 126-Week Data

David S. Liao, MD, PhD

ILM Flaps: 10 Years of Data

ILM Flaps: 10 Years of Data

Zofia A. Nawrocka, MD, PhD

When to Treat with Pegcetacoplan

When to Treat with Pegcetacoplan

Roger A. Goldberg, MD, MBA

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2025.